Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ODYSSEY HOUSE INC

NPI: 1407481245 · SALT LAKE CITY, UT 84102 · Addiction Medicine (Family Medicine) Physician · NPI assigned 03/11/2020

$10.13M
Total Medicaid Paid
99,367
Total Claims
80,446
Beneficiaries
40
Codes Billed
2020-04
First Month
2024-12
Last Month

Provider Details

Authorized OfficialCOHEN, ADAM (CEO)
NPI Enumeration Date03/11/2020

Related Entities

Other providers sharing the same authorized official: COHEN, ADAM

ProviderCityStateTotal Paid
ODYSSEY HOUSE INC SALT LAKE CITY UT $84.49M
SUPPORT CONNECTION LLC RED BANK NJ $2.53M
ODYSSEY HOUSE OF UTAH SALT LAKE CITY UT $95K
ADAM I COHEN DPT PC SOUTH OZONE PARK NY $41K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 9,007 $1.31M
2021 27,479 $3.28M
2022 27,105 $3.54M
2023 22,329 $1.41M
2024 13,447 $598K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 20,742 16,347 $4.42M
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 7,034 6,084 $1.73M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 7,623 6,355 $1.34M
J2315 Injection, naltrexone, depot form, 1 mg 2,953 2,495 $760K
99215 Prolong outpt/office vis 3,830 2,951 $531K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2,270 2,028 $374K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 7,725 5,032 $273K
Q9991 Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg 405 337 $188K
Q9992 Injection, buprenorphine extended-release (sublocade), greater than 100 mg 238 195 $126K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 7,312 4,486 $111K
80305 19,111 15,818 $75K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3,872 3,462 $48K
91301 891 843 $24K
81025 1,954 1,712 $23K
36415 Collection of venous blood by venipuncture 3,504 3,152 $12K
99496 89 83 $11K
99490 Ccm add 20min 1,081 983 $11K
99205 Prolong outpt/office vis 111 95 $11K
90686 784 729 $9K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 813 758 $9K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 123 115 $8K
91309 224 221 $6K
99406 2,781 2,553 $5K
86328 296 230 $4K
0011A 325 310 $3K
0094A 234 230 $3K
0012A 253 248 $3K
91303 76 67 $2K
99417 Prolong home eval add 15m 82 76 $2K
0013A 196 181 $2K
86580 478 456 $1K
99408 1,304 1,225 $521.74
86803 14 14 $199.98
J1885 Injection, ketorolac tromethamine, per 15 mg 78 69 $163.54
96127 127 122 $123.26
93000 12 12 $85.44
0031A 60 50 $80.00
81003 16 12 $15.30
86769 59 41 $0.00
99409 287 269 $0.00